000 01715 a2200517 4500
005 20250514024410.0
264 0 _c20020312
008 200203s 0 0 eng d
022 _a0021-9746
024 7 _a10.1136/jcp.55.2.98
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCruz, I
245 0 0 _aSuprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.
_h[electronic resource]
260 _bJournal of clinical pathology
_cFeb 2002
300 _a98-104 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aImmunoenzyme Techniques
650 0 4 _aLeukoplakia, Oral
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMouth Neoplasms
_xmetabolism
650 0 4 _aPrecancerous Conditions
_xmetabolism
650 0 4 _aPredictive Value of Tests
650 0 4 _aPrognosis
650 0 4 _aSensitivity and Specificity
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
700 1 _aNapier, S S
700 1 _avan der Waal, I
700 1 _aSnijders, P J F
700 1 _aWalboomers, J M M
700 1 _aLamey, P J
700 1 _aCowan, C G
700 1 _aGregg, T A
700 1 _aMaxwell, P
700 1 _aMeijer, C J L M
773 0 _tJournal of clinical pathology
_gvol. 55
_gno. 2
_gp. 98-104
856 4 0 _uhttps://doi.org/10.1136/jcp.55.2.98
_zAvailable from publisher's website
999 _c11772769
_d11772769